Physicians

Gene Therapy for Sanfilippo Syndrome Gets FDA Nod
- (MedPage Today) -- The FDA on Thursday approved rebisufligene etisparvovec (Fayuvi) as the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A,

















